Evaluation of the Synergistic Effect of EDTA-Functionalized Chitosan Nanoparticles on Imipenem Delivery in <i>Pseudomonas aeruginosa</i> Carbapenem-Resistant Strain AG1
- 1 National Nanotechnology Laboratory (LANOTEC), National Center for Advanced Technology Studies (CeNAT), San José, Costa Rica
- 2 National Nanotechnology Laboratory (LANOTEC), National Center for Advanced Technology Studies (CeNAT), San José, Costa Rica
- 3 Centro de Investigaciones en Enfermedades Tropicales (CIET), Facultad de Microbiología, Universidad de Costa Rica, San Pedro, Costa Rica
- 4 National Nanotechnology Laboratory (LANOTEC), National Center for Advanced Technology Studies (CeNAT), San José, Costa Rica
- 5 National Center for Biotechnological Innovations (CENIBiot), National Center for Advanced Technology Studies (CeNAT), San José, Costa Rica
Abstract
Metallo- β -lactamases are bacterial zinc-dependent enzymes involved in the hydrolysis of β -lactamic antibiotics representing the main cause of bacterial resistance to carbapenems, drugs of last resort for treating infections caused by multiresistant bacteria. We elaborated the hypothesis that it is possible to inhibit the enzymatic activity of metallo- β -lactamases by lowering the availability of zinc in the extracellular medium using metal chelating agents such as EDTA carried on nanoparticles. Chitosan, as linear cationic polysaccharide is frequently used in biomedical and pharmaceutical applications, has been studied as a biocompatible encapsulating agent in drug delivery systems and is an ideal transport agent for bioactive molecular complexes in antibiotic applica tions due to its ability to associate with negatively charged substances. We de veloped novel nanoparticles using chitosan as a transport matrix for β -lactamic antibiotics. Nanoparticles were synthesized according to the ion gelation method using tripolyphosphate as crosslinking agent. Nanoparticles were functionalized by the adsorption of EDTA, which acts as complexifying agent for Zn 2+ ions causing inhibition of metallo- β -lactamases activity. We evaluate the antimicrobial effects of EDTA-functionalized nanoparticles with an imipenem cargo on the clinical isolate P. aeruginosa AG1, a carbapenem-resistant high-risk clone ST-111 carrying both bla IMP-18 and bla VIM-2 metallo- β -lactamases genes.
- Breidenstein, E., de la Fuente-Núnez, C. and Hancock, R. (2011) Pseudomonas aeruginosa: All Roads Lead to Resistance. Trends in Microbiology, 19, 419-426. https://doi.org/10.1016/j.tim.2011.04.005
- Bonomo, R. and Szabo, D. (2006) Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa. Clinical Infectious Diseases, 43, S49-S56. https://doi.org/10.1086/504477
- Khalifa, A., Moissenet, D., Thien, H. and Khedher, M. (2011) Virulence Factors in Pseudomonas aeruginosa: Mechanisms and Modes of Regulation. Annales De Biologie Clinique, 69, 393-403.
- Lister, P., Wolter, D. and Hanson, N. (2009) Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clinical Microbiology Reviews, 22, 582-610. https://doi.org/10.1128/CMR.00040-09
- Master, R.N., Clark, R.B., Karlowsky, J.A., Ramirez, J. and Bordon, J.M. (2011) Analysis of Resistance, Cross-Resistance and Antimicrobial Combinations for Pseudomonas aeruginosa Isolates from 1997 to 2009. International Journal of Antimicrobial Agents, 38, 291-295. https://doi.org/10.1016/j.ijantimicag.2011.04.022
- Talbot, G.H., Bradley, J., Edwards, J.E., Gilbert, D., Sheld, M. and Barlett, J.G. (2006) Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clinical Infectious Diseases, 42, 657-668. https://doi.org/10.1086/499819
- Coates, A.R. (2012) Antibiotic Resistance. Handbook of Experimental Pharmacology. University of London. Springer, Berlin. https://doi.org/10.1007/978-3-642-28951-4
- Walsh, C. (2003) Antibiotics. Action, Origins, Resistance. ASM Press, Washington DC.
- Toval, F., Guzmán-Marte, A., Madriz, V., Somogyi, T., Rodriguez, C. and García, F. (2014) Predominance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates Carrying blaIMP and blaVIM Metallo—Lactamases in a Major Hospital in Costa Rica. Journal of Medical Microbiology, 64, 37-43. https://doi.org/10.1099/jmm.0.081802-0
- Boonsongrit, Y., Mitrevej, A. and Mueller, B. (2006) Chitosan Drug Binding by Ionic Interaction. European Journal of Pharmaceutics and Biopharmaceutics, 62, 267-274. https://doi.org/10.1016/j.ejpb.2005.09.002
- El-Sharif, A. and Hussain, M. (2010) Chitosan-EDTA New Combination Is a Promising Candidate for Treatment of Bacterial and Fungal Infections. Current Microbiology, 62, 739-745. https://doi.org/10.1007/s00284-010-9777-0